NRX Pharmaceuticals Inc (NRXP) — Financial Flexibility Index
NRX Pharmaceuticals Inc (NRXP) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-2.89 Million (operating CF $-2.89 Million minus capex $0.00) represents 0% of total liabilities ($40.75 Million). Check how tangible is NRX Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NRX Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NRX Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does NRX Pharmaceuticals Inc generate cash.
Annual Financial Flexibility Index for NRX Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for NRX Pharmaceuticals Inc. Explore NRXP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |